FDA Launches New Resource for Neurological Devices
FDA has launched a new website aimed at helping bring neurological medical devices to the U.S. market. The website is part of the agency’s support of the White House BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative.
“This webpage is intended to assist neurological device developers, sponsors and innovators with navigating the regulatory process. It provides insight into the premarket review process and the scientific and ethical considerations to bringing new neurological devices to market.” – FDA
The agency provides the following on the site:
- An overview of the FDA regulatory process, and how it applies to developers and sponsors of neurological devices
- Standards and guidances for neurological devices
- Regulatory science information related to neurological devices
- Information on patient perspectives and real world data in the development of neurological devices
- Resources, webinars, and events of interest to sponsors and developers of neurological devices
Related Articles
-
The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…
-
The MDDT program was developed in collaboration with the National Institutes of Health’s (NIH’s) National Institute of Drug Abuse (NIDA), National Institute of Dental Craniofacial Research (NIDCR) and National Cancer Institute (NCI) as a way for the FDA to qualify…
-
With the ever-increasing adoption of connected devices, the agency is emphasizing the need for effective cybersecurity.
-
The FDA is hosting a webinar on February 2 for interested stakeholders to discuss the final guidance Electromagnetic Compatibility (EMC) of Medical Devices and its applicability to in vitro diagnostic (IVD) devices.
